Biohaven (BHVN) Accumulated Expenses (2021 - 2026)

Biohaven (BHVN) has 6 years of Accumulated Expenses data on file, last reported at $41.7 million in Q1 2026.

• For the quarter ending Q1 2026, Accumulated Expenses fell 26.37% year-over-year to $41.7 million; the trailing twelve-month figure through Mar 2026 stood at $41.7 million (down 26.37% YoY), and the FY2025 full-year result was $104.3 million, up 102.56% from the prior year.
• Accumulated Expenses slipped to $41.7 million in Q1 2026, from $104.3 million in the prior quarter.
• In the past five years, Accumulated Expenses ranged from a high of $104.3 million in Q4 2025 to a low of $23.7 million in Q3 2022.
• A 5-year average of $54.1 million and a median of $51.5 million in 2024 frame the typical range for Accumulated Expenses.
• Across the five-year window, Accumulated Expenses jumped 122.05% in 2023 and declined 26.37% in 2026, its largest moves.
• Tracing BHVN's Accumulated Expenses over 5 years: stood at $44.1 million in 2022, then decreased by 9.66% to $39.8 million in 2023, then gained by 29.21% to $51.5 million in 2024, then surged by 102.56% to $104.3 million in 2025, then sank by 60.06% to $41.7 million in 2026.
• Business Quant data shows BHVN's Accumulated Expenses at $41.7 million in Q1 2026, $104.3 million in Q4 2025, and $73.5 million in Q3 2025.